In this issue:
Aspirin 'resistance' and CV morbidity
Drug-eluting stents vs CABG
VTE risk with warfarin interruption
Idraparinux vs vitamin K antagonists for VTE prevention in AF
Outcomes in asymptomatic severe aortic stenosis
Non-specific immunomodulation therapy in CH
Please login below to download this issue (PDF)